May 6, 2019
Acadia Healthcare Company, Inc.
, which operates outpatient drug treatment centers in West Virginia through its subsidiary CRC Health, L.L.C.
, will pay $17 million
to resolve claims that it improperly billed the state's Medicaid program for urine and blood testing services as if they had performed the testing themselves, despite the fact that Acadia lacked the certification to perform the tests. In fact, the testing was performed by an independent outside laboratory, and that lab independently billed Medicaid for the tests, at a lower rate. Medicaid paid Acadia’s treatment centers $8,500,000 for the improperly-billed tests. As part of this settlement, defendants also entered into a five-year corporate integrity agreement to maintain specified compliance programs and procedures. USAO SDWV